ADCO-LINCTOPENT SYRUP is a specialized medication formulated to relieve cough associated with bronchospasm and thick phlegm. It exhibits mucolytic and bronchodilatory properties, making it particularly effective in respiratory conditions where excessive mucus production and airway constriction are present.
Composition
Each 5 ml of ADCO-LINCTOPENT SYRUP contains:
| Ingredient | Amount | Function |
|---|---|---|
| Bromhexine hydrochloride | 4 mg | Mucolytic agent that helps in breaking down thick mucus. |
| Orciprenaline sulphate | 5 mg | Bronchodilator that aids in relieving bronchospasm. |
Preservatives:
- Methyl parahydroxybenzoate (0.05% m/v)
- Propyl parahydroxybenzoate (0.01% m/v)
Excipients:
- Strawberry liquid flavouring
- Glycerine (Glycerol)
- Kollidon 90/Kollidon 90F (Povidone)
- Propylene glycol
- Sorbitol 70% (Non-Crystalline) solution
- Purified water
The formulation is alcohol-free and sugar-free, making it suitable for a broad range of patients, including those with diabetes.
Pharmacological Classification
ADCO-LINCTOPENT SYRUP belongs to Pharmacological Classification A 10.1, which includes medicines that act on the respiratory system, specifically antitussives and expectorants.
Pharmacological Action
ADCO-LINCTOPENT SYRUP provides both mucolytic and bronchodilatory effects.
- Mucolytic Effect: Bromhexine hydrochloride works by reducing mucus viscosity, making it easier to clear phlegm from the airways.
- Bronchodilatory Effect: Orciprenaline sulphate relaxes the smooth muscles of the bronchi, easing breathing difficulties associated with airway constriction.
Indications
This medication is indicated for the relief of:
- Cough associated with bronchospasm, which causes wheezing due to airway narrowing.
- Thick and tenacious phlegm that is difficult to expectorate.
contraindications
ADCO-LINCTOPENT SYRUP should not be used in the following situations:
- Hypersensitivity to sympathomimetic amines or any other ingredient in the formulation.
- Hypertrophic obstructive cardiomyopathy, a condition where the heart muscle thickens abnormally.
- Tachyarrhythmia, which refers to irregular and fast heart rhythms.
- Patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days after discontinuing MAOIs, due to the risk of severe interactions.
- The safety of this medication in pregnant and lactating women has not been established, and its use should be avoided in these cases.
Dosage and Directions for Use
| Age Group | Dosage | Frequency |
|---|---|---|
| Adults & Children Over 12 Years | 10 to 20 ml | Three times daily |
| Children (3 to 12 Years) | 5 to 10 ml | Three times daily |
| Children (1 to 3 Years) | 2.5 to 5 ml | Three times daily |
| Infants | 2.5 ml | Three times daily |
Exceeding the recommended dose can lead to unwanted side effects and should be avoided.
Side Effects and Special Precautions
Side Effects:
| Ingredient | Possible Side Effects |
|---|---|
| Bromhexine hydrochloride | Gastric irritation, transient elevation in liver enzyme levels. |
| Orciprenaline sulphate | Anxiety, restlessness, tremors, insomnia, increased heart rate, palpitations, cardiac arrhythmias, nausea, vomiting, muscle cramps, dizziness, and sweating. |
Special Precautions:
- Should be avoided in patients undergoing anesthesia with halogenated anesthetics as it may induce ventricular fibrillation.
- There is an increased risk of arrhythmias in patients taking cardiac glycosides or antidepressants.
- Caution is required for patients with the following conditions:
- Hyperthyroidism: Risk of excessive sympathomimetic effects.
- Gastric ulcers: Risk of worsening due to mucolytic action.
- Cardiovascular diseases: Includes hypertension, ischemic heart disease, and arrhythmias.
- Diabetes mellitus: Risk of blood sugar fluctuations.
- Glaucoma: May increase intraocular pressure.
- Epilepsy: Risk of seizures.
Drug Interactions
Certain medications may interact with ADCO-LINCTOPENT SYRUP and should be used with caution.
| Interacting Drug Class | Potential Interaction |
|---|---|
| Cardiac Glycosides (e.g., Digitalis, Quinidine) | May require dose adjustment due to positive inotropic effects. |
| Beta-Blockers | Should not be co-administered as orciprenaline reverses their antihypertensive action. |
| Other Sympathomimetics | Risk of excessive stimulation if combined. |
Overdosage Symptoms and Treatment

Symptoms of Overdosage:
- Palpitations
- Tremors
- Hypotension (low blood pressure)
Treatment:
- Supportive and symptomatic care should be provided.
- Gastric lavage may be considered in severe cases.
- A cardio-selective beta-blocker may be used cautiously to counteract excessive bronchodilation but must be administered carefully to avoid inducing severe bronchospasm.
Identification and Presentation
Identification:
- ADCO-LINCTOPENT SYRUP is a clear, colorless to pale yellow liquid with a strawberry flavor.
Presentation:
- Packaged in amber glass bottles.
- Available in 100 ml and 200 ml containers.
Storage Instructions
- Store in an airtight container at or below 25°C.
- Protect from light to maintain stability and effectiveness.
- Keep out of reach of children.
Conclusion
ADCO-LINCTOPENT SYRUP is an effective treatment for coughs associated with wheezing and thick mucus. However, due to its pharmacological properties, it must be used with caution, particularly in individuals with cardiovascular, metabolic, or neurological conditions. Always adhere to recommended dosages and consult a healthcare provider for guidance, especially in vulnerable patient groups such as children, the elderly, and those with pre-existing conditions.
By following the prescribed guidelines, patients can benefit from its expectorant and bronchodilator effects while minimizing potential risks.
Education:
NPU (National Pharmaceutical University) 2010-2015, 2015-2016 internship
Work experience:
2010 – 2012 Pharmacy 63 – Production Department
2012 – 2015 Pharmacy 63 – Pharmacist
2015 – 2016 Pharmacy 63 – Pharmacist
2016 – to date Pharmacy UA – Head of Pharmacy






